Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection

Stopped Because of the difficulty of research operation, we changed to another research design.

Conditions

• Carcinoma, Non-Small-Cell Lung
• Chemotherapy, Adjuvant

Interventions

• DRUG: Shenlingcao Oral Liquid

Sponsor

West China Hospital